| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Triacylglycerol lipase measurement |
Has measured component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| dosage de la lipase |
Has measured component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluid sample lipase measurement |
Has measured component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Serum lipase measurement |
Has measured component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fecal lipase measurement (procedure) |
Has measured component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triacylglycerol lipase measurement |
Component |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| dosage de la lipase |
Component |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fluid sample lipase measurement |
Component |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Serum lipase measurement |
Component |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fecal lipase measurement (procedure) |
Component |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pancreatic lipase (substance) |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sphingomyelin phosphodiesterase (substance) |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lipoprotein lipase |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ceramidase |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acid lipase |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phospholipase (substance) |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hepatic triglyceride lipase (substance) |
Is a |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 66400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 3000unt/2400unt/3000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 20000unt/4500unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Amylase + lipase + protease 30000unt/8000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 16600unt/5000unt/18750unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 30000unt/8000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 30000unt/10000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase, amylase:lipase 184.84mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase, amylase:lipase 4500unit capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase, pancreatic + protease, pancreatic 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase (amylase;lipase 62.81% capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 40000unt/8000unt/45000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 33200unt/10000unt/37500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 12000unt/4000unt/12000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 39000unt/12000unt/39000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing amylase and substance with protease mechanism of action and triacylglycerol lipase |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase- and pancrelipase- and triacylglycerol lipase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Pancrelipase (amylase;lipase 62.81% (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 6000unt/16000unt/6000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 664400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 70000unt/16800unt/70000unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase, amylase:lipase 312.17mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 56000unt/20000unt/44000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase, amylase:lipase 346.86mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 58500unt/18000unt/58500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 20000unt/5000unt/20000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 25000unt/4000unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amylase + lipase + protease 48000unt/16000unt/48000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase (amylase;lipase 210.33mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase (amylase;lipase 183.49mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase (amylase;lipase 94.3mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pancrelipase (amylase;lipase 278.72% capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing only amylase and substance with protease mechanism of action and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase and pancrelipase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase and endopeptidase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase- and endopeptidase- and triacylglycerol lipase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triacylglycerol lipase (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]